NCT02345265 2026-03-05Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting70 enrolled 16 charts
NCT05276973 2025-12-19Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting25 enrolled 14 charts